What is Continuum Clinical?
Founded in 1993 and operating as a key component of Blue Chip Worldwide, Continuum Clinical serves as a specialized nexus for healthcare research and communications. Headquartered in Northbrook, Illinois, with an expansive international footprint spanning Chicago, London, and Zikhron Yaakov, the firm provides critical infrastructure for clinical trial success. Their service portfolio encompasses sophisticated patient recruitment strategies, physician communications, and health economics, positioning them as an essential partner for pharmaceutical and biotech enterprises navigating complex regulatory and market landscapes.
How much funding has Continuum Clinical raised?
Continuum Clinical has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in Continuum Clinical
PPP
Public-Private Partnership
What's next for Continuum Clinical?
With this major strategic investment, Continuum Clinical is poised to accelerate its digital transformation and expand its proprietary research methodologies. The capital will likely be deployed to enhance the firm's data-driven patient engagement platforms, ensuring that clinical trial timelines are optimized through precision recruitment. As the healthcare sector increasingly prioritizes real-world evidence and patient-centric outcomes, Continuum Clinical is strategically positioned to capture additional market share by integrating advanced analytics into its established communications framework. Future growth will likely focus on deepening its presence in the European and Middle Eastern markets, further cementing its role as a global leader in clinical research support services.
See full Continuum Clinical company page
